Evidence map›Paper›PMID 41724886›Full record

ArticleJournal of mathematical biology2026

Optimizing insecticide deployment strategies to delay quantitative resistance in mosquito populations.

Sylvère Kezeta-Bondja, Charles S Wondji, Ramsès Djidjou-Demasse

Abstract read
In one paragraph

Article in Journal of mathematical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sylvère Kezeta-BondjaCentre for Research in Infectious Diseases, Yaoundé, Yaoundé, Cameroon.
Charles S WondjiCentre for Research in Infectious Diseases, Yaoundé, Yaoundé, Cameroon.
Ramsès Djidjou-DemasseMIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France. ramses.djidjoudemasse@ird.fr.ORCID http://orcid.org/0000-0003-1684-5190

Funding

Bill and Melinda Gates Foundation INV-047049
6 · The paper itself

Abstract

The large-scale use of insecticides remains a cornerstone of malaria vector control, but its long-term effectiveness is undermined by the evolution of quantitative insecticide resistance (qIR) in mosquito populations. We develop and analyze a mathematical model to identify optimal deployment strategies for two insecticides that differ only in their relative efficacy against target mosquito populations. Resistance is represented as a continuous phenotypic trait influencing mosquito fecundity and mortality, and the model accounts for successive deployment periods. Our results show that when mutational variance is high, the optimal strategy is to deploy the most effective insecticide at full coverage, regardless of its relative efficacy or pre-deployment exposure history. By contrast, when mutational variance is low, optimal deployment requires a transient reduction in coverage during early periods, with a threshold effect driven by both relative efficacy and initial exposure rates. Crucially, we find that, under the hypothesis that the first insecticide is ineffective against mosquitoes, simultaneous use of both insecticides is rarely optimal. Instead, sequential deployment-using one insecticide until resistance reaches a critical threshold, followed by optimal use of the second-delays resistance evolution and improves long-term control. These findings provide a theoretical foundation for adaptive qIR management strategies aimed at prolonging the effectiveness of insecticides in malaria vector control.

Indexed as

CulicidaeInsecticide ResistanceInsecticidesModels, BiologicalMosquito ControlMosquito VectorsAnimalsMalariaMathematical ConceptsMutationInsecticidesAdaptive insecticide managementNonlinear dynamical systemsOptimal control strategiesQuantitative insecticide resistanceStructured mathematical model

Identifiers

PMID41724886
PMCPMC12926253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.